{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:31:12Z","timestamp":1760981472232},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T00:00:00Z","timestamp":1153440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s00432-006-0138-0","type":"journal-article","created":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T06:53:10Z","timestamp":1153378390000},"page":"745-755","source":"Crossref","is-referenced-by-count":45,"title":["Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy"],"prefix":"10.1007","volume":"132","author":[{"given":"Thomas J.","family":"Vogl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Hochmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Hammerstingl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Zangos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,21]]},"reference":[{"key":"138_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1440-1673.1999.00629.x","volume":"43","author":"SH Al-Bassam","year":"1999","unstructured":"Al-Bassam SH, Munk PL, Sallomi DF et al (1999) Chemoembolization of hepatic tumours. Australas Radiol 43:165\u2013174","journal-title":"Australas Radiol"},{"issue":"4","key":"138_CR2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jamcollsurg.2005.12.012","volume":"202","author":"S Asthana","year":"2006","unstructured":"Asthana S, Jones D, Lodge JP (2006) Surgical management of recurrent liver tumors involving hepatic venous outflow. J Am Coll Surg 202(4):711\u2013713","journal-title":"J Am Coll Surg"},{"issue":"2","key":"138_CR3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00002820-199904000-00011","volume":"22","author":"M Barton-Burke","year":"1999","unstructured":"Barton-Burke M (1999) Gemcitabine: a pharmacologic and clinical overview. Cancer Nurs 22(2):176\u2013183","journal-title":"Cancer Nurs"},{"key":"138_CR4","unstructured":"Bengmark S, Ekberg H, Tranberg KG (1988) Metastatic tumors of the liver. In: Blumgart LH (eds) Surgery of the liver and biliary tract, vol 2. Churchill Livingstone, Edinburgh, London, Melbourne, New York, pp 1179\u20131189"},{"key":"138_CR5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1155\/2000\/815454","volume":"14","author":"FX Bosch","year":"2000","unstructured":"Bosch FX, Ribes J (2000) Epidemiology of liver cancer in Europe. Can J Gastroenterol 14:621\u2013630","journal-title":"Can J Gastroenterol"},{"key":"138_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007117","volume":"19","author":"FX Bosch","year":"1999","unstructured":"Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271\u2013285","journal-title":"Semin Liver Dis"},{"key":"138_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.coc.0000046580.51486.FF","volume":"27","author":"H Bourgeois","year":"2004","unstructured":"Bourgeois H, Billiart I, Chabrun V et al (2004) Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma. Am J Clin Oncol 27:89\u201394","journal-title":"Am J Clin Oncol"},{"key":"138_CR8","first-page":"1016","volume":"39","author":"B Brasiuniene","year":"2003","unstructured":"Brasiuniene B, Juozaityte E, Brasiunas V, Inciura A (2003) The update on pancreatic cancer chemotherapy. Medicina (Kaunas) 39:1016\u20131025","journal-title":"Medicina (Kaunas)"},{"issue":"suppl 1","key":"138_CR9","first-page":"191","volume":"33","author":"H Burris","year":"1997","unstructured":"Burris H, Storniolo AM (1997) Assessing the clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur J Cancer 33(suppl 1):191\u2013201","journal-title":"Eur J Cancer"},{"issue":"4","key":"138_CR10","first-page":"709","volume":"109","author":"A Cenusa","year":"2005","unstructured":"Cenusa A (2005) Hepatocellular carcinoma therapeutic action: hepatic resection and liver transplantation. Rev Med Chir Soc Med Nat Iasi 109(4):709\u2013712","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"138_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000018691","volume":"16","author":"M Falconi","year":"1999","unstructured":"Falconi M, Bassi C, Bonora A et al (1999) Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumors. Dig Surg 16:32\u201338","journal-title":"Dig Surg"},{"issue":"12","key":"138_CR12","first-page":"1124","volume":"4","author":"DB Geffen","year":"2002","unstructured":"Geffen DB, Man S (2002) New drugs for the treatment of cancer, 1990\u20132001. Isr Med Assoc J 4(12):1124\u20131131","journal-title":"Isr Med Assoc J"},{"key":"138_CR13","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/cncr.11726","volume":"98","author":"BJ Gitlitz","year":"2003","unstructured":"Gitlitz BJ, Baker C, Chapman Y, Allen HJ et al (2003) A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma. Cancer 98:1863\u20131869","journal-title":"Cancer"},{"key":"138_CR14","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/jlts.2000.18688","volume":"6","author":"GJ Gores","year":"2000","unstructured":"Gores GJ (2000) Early detection and treatment of cholangiocarcinoma. Liver Transpl 6:S30\u2013S34","journal-title":"Liver Transpl"},{"issue":"12","key":"138_CR15","first-page":"1219","volume":"168","author":"H Gronbaek","year":"2006","unstructured":"Gronbaek H, Levertumorgruppen AS (2006) Hepatocellular carcinoma and other liver tumors. The Danish Society of Hepatology (DASL) Ugeskr Laeger 168(12):1219","journal-title":"The Danish Society of Hepatology (DASL) Ugeskr Laeger"},{"key":"138_CR16","doi-asserted-by":"crossref","unstructured":"Guarneri V, Conte PF (2004) The curability of breast cancer and the treatment of advanced disease. Eur J Nucl Med Mol Imaging. Jun; 31(Suppl 1):S149\u2013S161 [Epub 2004 Apr 24 review]","DOI":"10.1007\/s00259-004-1538-5"},{"key":"138_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1024\/1023-9332.5.3.111","volume":"5","author":"U Hanack","year":"1999","unstructured":"Hanack U, Lorf T, Binder L et al (1999) Surgical treatment of cholangiocellular carcinoma. Swiss Surg 5:111\u2013115","journal-title":"Swiss Surg"},{"key":"138_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjsurg.2004.01.007","volume":"187","author":"JL Huang","year":"2004","unstructured":"Huang JL, Biehl TR, Lee FT et al (2004) Outcomes after resection of cholangiocellular carcinoma. Am J Surg 187:612\u2013617","journal-title":"Am J Surg"},{"key":"138_CR19","unstructured":"Hui YF, Reitz J (1997) Gemcitabine: a cytidine analogue active against solid tumors. Am J Health Syst Pharm 54:162\u2013170; quiz 197\u2013198"},{"key":"138_CR20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4757-3371-6_4","volume":"109","author":"SM Jones","year":"2001","unstructured":"Jones SM, Roh MS (2001) Results of surgical resection for hepatocellular carcinoma. Cancer Treat Res 109:59\u201375","journal-title":"Cancer Treat Res"},{"key":"138_CR21","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1056\/NEJM199912303412702","volume":"341","author":"N Kemeny","year":"1999","unstructured":"Kemeny N, Huang Y, Cohen AM et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2034\u20132048","journal-title":"N Engl J Med"},{"key":"138_CR22","first-page":"2459","volume":"19","author":"R Klapdor","year":"1999","unstructured":"Klapdor R, Seutter E, Lang-Polckow EM et al (1999) Locoregional\/systemic chemotherapy of locally advanced\/metastasized pancreatic cancer with a combination of mitomycin C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers. Anticancer Res 19:2459\u20132469","journal-title":"Anticancer Res"},{"key":"138_CR23","first-page":"783","volume":"48","author":"S Kubicka","year":"2001","unstructured":"Kubicka S, Rudolph KL, Tietze MK et al (2001) Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 48:783\u2013789","journal-title":"Hepatogastroenterology"},{"key":"138_CR24","first-page":"88","volume":"122","author":"P Lamesch","year":"1997","unstructured":"Lamesch P, Weimann A, Hauss J, Pichlmayr R (1997) Surgical treatment of intrahepatic cholangiocarcinoma. Chirurgie 122:88\u201391","journal-title":"Chirurgie"},{"issue":"3","key":"138_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-005-1566-3","volume":"40","author":"JM Llovel","year":"2005","unstructured":"Llovel JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40(3):225\u2013235","journal-title":"J Gastroenterol"},{"key":"138_CR26","first-page":"637","volume":"125","author":"T Lorf","year":"2000","unstructured":"Lorf T, Hanack U, Schworer H et al (2000) Surgical treatment of cholangiocellular carcinoma and proximal bile duct tumors. Zentralbl Chir 125:637\u2013641","journal-title":"Zentralbl Chir"},{"issue":"9","key":"138_CR27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-2036.2006.02900.x","volume":"23","author":"H Malhi","year":"2006","unstructured":"Malhi H, Gores GJ (2006) Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther 1 23(9):1287\u20131296","journal-title":"Aliment Pharmacol Ther 1"},{"issue":"4","key":"138_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1157\/13085990","volume":"29","author":"C Margarit","year":"2006","unstructured":"Margarit C, Escartin A, Bellmunt J, Allende E, Bilbao I (2006) Peripheral cholangiocarcinoma: results of surgical treatment. Gastroenterol Hepatol 29(4):215\u2013223","journal-title":"Gastroenterol Hepatol"},{"key":"138_CR29","first-page":"469","volume":"58","author":"R Martin","year":"2003","unstructured":"Martin R, Jarnagin W (2003) Intrahepatic cholangiocarcinoma. Current management. Minerva Chir 58:469\u2013478","journal-title":"Current management. Minerva Chir"},{"issue":"3","key":"138_CR30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1072-7515(00)00789-4","volume":"192","author":"Y Nakajima","year":"2001","unstructured":"Nakajima Y, Ko S, Kanamura T, Nagao M, Kanehiro H, Hisanaga M, Aomatsu Y, Ikeda N, Nakano H (2001) Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 192(3):339\u2013344","journal-title":"J Am Coll Surg"},{"issue":"2","key":"138_CR31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00130404-200403000-00003","volume":"10","author":"TM Pawlik","year":"2004","unstructured":"Pawlik TM, Scoggins CR, Thomas MB, Vauthey JN (2004) Advances in the surgical management of liver malignancies. Cancer J 10(2):74\u201387","journal-title":"Cancer J"},{"key":"138_CR32","first-page":"51","volume":"48","author":"P Price","year":"2001","unstructured":"Price P (2001) Cholangiocarcinoma and the role of radiation and chemotherapy. Hepatogastroenterology 48:51\u201352","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"138_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.clon.2005.05.006","volume":"17","author":"JD Raguse","year":"2005","unstructured":"Raguse JD, Gath HJ, Bier J, Riess H, Oettle H (2005) Gemcitabine in the treatment of advanced head and neck cancer. Clin Oncol (R Coll Radiol) 17(6):425\u2013429","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"138_CR34","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.2004.10.142","volume":"22","author":"JM Reid","year":"2004","unstructured":"Reid JM, Qu W, Safgren SL, Ames MM et al (2004) Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors. J Clin Oncol 22:2445\u20132451","journal-title":"J Clin Oncol"},{"key":"138_CR35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4615-2604-9_21","volume":"69","author":"B Ringe","year":"1994","unstructured":"Ringe B, Weimann A, Lamesch P et al (1994) Liver transplantation as an option in patients with cholangiocellular and bile duct carcinoma. Cancer Treat Res 69:259\u2013275","journal-title":"Cancer Treat Res"},{"issue":"Suppl 6","key":"138_CR36","first-page":"521","volume":"59","author":"H Sakaguchi","year":"2001","unstructured":"Sakaguchi H, Uchida H, Tanaka T et al (2001) Transcatheter arterial embolization\/chemoembolization. Nippon Rinsho 59(Suppl 6):521\u2013527","journal-title":"Nippon Rinsho"},{"key":"138_CR37","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1023\/A:1008369718242","volume":"11","author":"AB Sandler","year":"2000","unstructured":"Sandler AB, Kindler HL, Einhorn LH et al (2000) Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction. Ann Oncol 11:1161\u20131164","journal-title":"Ann Oncol"},{"issue":"2","key":"138_CR38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/sonc.2002.31676","volume":"29","author":"AR Sasson","year":"2002","unstructured":"Sasson AR, Sigurdson ER (2002) Surgical treatment of liver metastases. Semin Oncol 29(2):107\u2013118","journal-title":"Semin Oncol"},{"key":"138_CR39","first-page":"1170","volume":"18","author":"P Spagnuolo","year":"1999","unstructured":"Spagnuolo P, Roversi R, Rossi G et al (1999) Phase II study of gemcitabine for treatment of inoperable pancreatic and cholangiocarcinoma. Proc Am Soc Clin Oncol 18:1170","journal-title":"Proc Am Soc Clin Oncol"},{"key":"138_CR40","first-page":"118","volume":"5","author":"P Srivatanakul","year":"2004","unstructured":"Srivatanakul P, Sriplung H, Deerasamee S (2004) Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 5:118\u2013125","journal-title":"Asian Pac J Cancer Prev"},{"key":"138_CR41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/02841868709089978","volume":"26","author":"H Starkhammer","year":"1987","unstructured":"Starkhammer H, Hakansson L, Morales O, Svedberg J (1987) Intraarterial Mytomycin C treatment of unresectable liver tumors. Preliminary results on the effect of degradable starch microspheres. Acta Oncol 26:295\u2013300","journal-title":"Acta Oncol"},{"issue":"5","key":"138_CR42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1634\/theoncologist.8-5-425","volume":"8","author":"K Stuart","year":"2003","unstructured":"Stuart K (2003) Chemoembolization in the management of liver tumors. Oncologist 8(5):425\u2013437","journal-title":"Oncologist"},{"issue":"1","key":"138_CR43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00108-003-1110-6","volume":"45","author":"A Tannapfel","year":"2004","unstructured":"Tannapfel A, Wittekind C (2004) Gallbladder and bile duct carcinoma. Biology and pathology. Internist (Berl) 45(1):33\u201341","journal-title":"Biology and pathology. Internist (Berl)"},{"key":"138_CR44","first-page":"119","volume":"160","author":"PG Tarazov","year":"2001","unstructured":"Tarazov PG (2001) Preoperative arterial chemoembolization in malignant tumors of the liver. Vestn Khir Im I Grek 160:119\u2013123","journal-title":"Vestn Khir Im I Grek"},{"issue":"4","key":"138_CR45","first-page":"770","volume":"109","author":"E Tarcoveanu","year":"2005","unstructured":"Tarcoveanu E, Lupascu C, Georgescu S, Zugun F, Crumpei F, Epure O, Nicorici C, Canschi G, Ferariu D (2005) Liver resection for hepatocellular carcinoma in cirrhotic patients. Rev Med Chir Soc Med Nat Iasi 109(4):770\u2013780","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"1","key":"138_CR46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14796694.1.1.7","volume":"1","author":"L Toschi","year":"2005","unstructured":"Toschi L, Finocchiaro G, Bartolini S, Gioia V, Capuzzo F (2005) Role of gemcitabine in cancer therapy. Future Oncol 1(1):7\u201317","journal-title":"Future Oncol"},{"key":"138_CR47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/B:DRUG.0000011797.09549.53","volume":"22","author":"N Tsavaris","year":"2004","unstructured":"Tsavaris N, Kosmas C, Gouveris P et al (2004) Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Invest New Drugs 22:193\u2013198","journal-title":"Invest New Drugs"},{"key":"138_CR48","first-page":"832","volume":"47","author":"T Uenishi","year":"2000","unstructured":"Uenishi T, Hirohashi K, Shuto T et al (2000) Surgery for mixed hepatocellular and cholangiocellular carcinoma. Hepatogastroenterology 47:832\u2013834","journal-title":"Hepatogastroenterology"},{"key":"138_CR49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00001813-200010000-00006","volume":"11","author":"F Verderame","year":"2000","unstructured":"Verderame F, Mandina P, Abruzzo F et al (2000) Biliary tract cancer: our experience with gemcitabine treatment. Anticancer Drugs 11:707\u2013708","journal-title":"Anticancer Drugs"},{"key":"138_CR50","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-2003-39212","volume":"175","author":"TJ Vogl","year":"2003","unstructured":"Vogl TJ, Heller M, Zangos S, Schwarz W et al (2003) Transarterial chemoperfusion of inoperable pancreas carcinoma and local recurrence. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 175:695\u2013704","journal-title":"Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr"},{"key":"138_CR51","first-page":"1170","volume":"18","author":"A Weissmann","year":"1999","unstructured":"Weissmann A, Ludwig H (1999) Intraarterial gemcitabine for treatment of inoperable pancreatic and cholangiocarcinoma. Proc Am Soc Clin Oncol 18:1170","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"8","key":"138_CR52","first-page":"478","volume":"27","author":"EH Xiao","year":"2005","unstructured":"Xiao EH, Hu GD, Li JQ, Huang JF (2005) Transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 27(8):478\u2013482","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"138_CR53","first-page":"43","volume":"51","author":"S Yalcin","year":"2004","unstructured":"Yalcin S (2004) Diagnosis and management of cholangiocarcinomas: a comprehensive review. Hepatogastroenterology 51:43\u201350","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"138_CR54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cgh.2005.12.022","volume":"4","author":"L Yu","year":"2006","unstructured":"Yu L, Sloane DA, Guo C, Howell CD (2006) Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000. Clin Gastroenterol Hepatol 4(3):355\u201360","journal-title":"Clin Gastroenterol Hepatol"},{"key":"138_CR55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1155\/2000\/371801","volume":"14","author":"MC Yu","year":"2000","unstructured":"Yu MC, Yuan JM, Govindarajan S, Ross RK (2000) Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 14:703\u2013709","journal-title":"Can J Gastroenterol"},{"key":"138_CR56","unstructured":"Zaloudik J, Kocak I, Pacovsky Z, Karasek P, Fait V, Bartonkova H, Nekulova M (1997) Regional chemotherapy of liver tumors. Vnitr Lek 43(3):171\u2013172"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-006-0138-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-006-0138-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-006-0138-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:39:41Z","timestamp":1559068781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-006-0138-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,21]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1007\/s00432-006-0138-0","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,21]]}}}